| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Indication | Essai clinique |
|---|---|---|---|---|---|
| Bexotegrast | PLN-74809 | Phase 3 Clinical | Pliant Therapeutics Inc | Idiopathic Pulmonary Fibrosis; Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult; Cholangitis, Sclerosing | Details |
| IDL-2965 | IDL-2965 | Phase 2 Clinical | Indalo Therapeutics Inc | Metabolic Dysfunction-Associated Steatotic Liver Disease; Idiopathic Pulmonary Fibrosis | Details |
| PLN-1474 | PLN-1474 | Phase 1 Clinical | Pliant Therapeutics Inc, Novartis Pharma Ag | Metabolic Dysfunction-Associated Steatotic Liver Disease; Liver Cirrhosis | Details |